Skip to main content

Gentiana lutea L. (Gentianaceae)

  • Chapter
  • First Online:
Handbook of 200 Medicinal Plants

Abstract

It is a perennial plant that grows naturally in the central and southern areas of Europe. Dioscorides described two types: one called Roman that grows in damp, cold and snowy mountains; the second type also grows in damp places, but its roots are less bitter and weaker in properties than the first one. Gentian is anthelmintic, antiseptic, emmenagogue, febrifuge, stimulant, stomachic, and tonic, and is used to stimulate gastric secretion, improve appetite and digestion and alleviate debility; also, for blood disorders, cancer, cold, convulsions, diarrhea, dog-bite, dysmenorrhea, dyspepsia, gastritis, gout, jaundice, malaria, oliguria, snakebite, splenitis, stomachache, syncope and wounds. In the central and southern Europe, gentian extract is used in nonalcoholic beverages, frozen dairy desserts, candy, baked goods, gelatins and puddings; and in some antismoking compounds and cosmetics. In Montenegro, leaves are traditionally utilized as hepatoprotective, hypoglycemic and anti-inflammatory agents. G. lutea is approved for GI disorders use in Europe since Sep. 2007 by the HMPC of the European Medicines Agency. The roots contain glucosides: gentiopicrine; also, gentiamarine, amarogentine, the glycoside gentiin; the tannin like principle gentiamarin, gentisin, gentisic acid and the trisaccharide gentianose, triterpinoids, iridoids, secoiridoids, xanthones, xanthone glycosides, and MAO-B inhibitors. Amarogentin is one of the most bitter natural compounds and is used to measure comparative bitterness. In a crossover randomized study, a microencapsulated bitter ingredient of the root extract consumed by twenty healthy subjects at breakfast on two different occasions, significantly reduced energy intake over the postlunch period, and showed a trend for a higher response of glucagon-like peptide-1, but no significant difference from placebo on appetite. Administration of gentian flavored water to healthy individuals increased peripheral vascular resistance and decreased cardiac output, primarily by reducing stroke volume.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Tayyab M: Personal Communication.

References

  1. Aberham A, Schwaiger S, Stuppner H, Ganzera M. Quantitative analysis of iridoids, secoiridoids, xanthones and xanthone glycosides in Gentiana lutea L. roots by RP-HPLC and LC-MS. J Pharm Biomed Anal. 2007;45:437–42.

    Google Scholar 

  2. Akileshwari C, Muthenna P, Nastasijević B, et al. Inhibition of aldose reductase by Gentiana lutea extracts. Exp Diabetes Res. 2012;2012:147965.

    Article  Google Scholar 

  3. Amin A. Ketoconazole-induced testicular damage in rats reduced by Gentiana extract. Exp Toxicol Pathol. 2008;59:377–84.

    Article  CAS  Google Scholar 

  4. Bakuridze AD, Nikolaev SM, Tsagarenshvili NT, et al. Influence of Gentiana lutea L. extract on blood coagulation. Georgian Med News. 2009;172–173:89–91 (Article in Russian).

    Google Scholar 

  5. Balijagić J, Janković T, Zdunić G, et al. Chemical profile, radical scavenging and cytotoxic activity of yellow gentian leaves (Genitaneae luteaefolium) grown in northern regions of Montenegro. Nat Prod Commun. 2012;7:1487–90.

    PubMed  Google Scholar 

  6. Bianco A, Ramunno A, Melchioni C. Iridoids from seeds of Gentiana lutea. Nat Prod Res. 2003;17:221–4.

    Article  CAS  Google Scholar 

  7. Calliste CA, Trouillas P, Allais DP, et al. Free radical scavenging activities measured by electron spin resonance spectroscopy and B16 cell antiproliferative behaviors of seven plants. J Agric Food Chem. 2001;49:3321–7.

    Article  CAS  Google Scholar 

  8. Chen L, Liu JC, Zhang XN, et al. Downregulation of NR2B receptors partially contributes to analgesic effects of Gentiopicroside in persistent inflammatory pain. Neuropharmacology. 2008;54:1175–81.

    Article  CAS  Google Scholar 

  9. Citová I, Ganzera M, Stuppner H, Solich P. Determination of gentisin, isogentisin, and amarogentin in Gentiana lutea L. by capillary electrophoresis. J Sep Sci. 2008;31:195–200.

    Google Scholar 

  10. Haraguchi H, Tanaka Y, Kabbash A, et al. Monoamine oxidase inhibitors from Gentiana lutea. Phytochemistry. 2004;65:2255–60.

    Article  CAS  Google Scholar 

  11. Kakuda R, Machida K, Yaoita Y, et al. Studies on the constituents of Gentiana species. II. A new triterpenoid, and (S)-(+)- and (R)-(−)-gentiolactones from Gentiana lutea. Chem Pharm Bull (Tokyo). 2003;51:885–7.

    Google Scholar 

  12. Kesavan R, Potunuru UR, Nastasijević B, et al. Inhibition of vascular smooth muscle cell proliferation by Gentiana lutea root extracts. PLoS One. 2013;8:e61393.

    Article  CAS  Google Scholar 

  13. Kesavan R, Chandel S, Upadhyay S, et al. Gentiana lutea exerts anti-atherosclerotic effects by preventing endothelial inflammation and smooth muscle cell migration. Nutr Metab Cardiovasc Dis. 2016;26:293–301.

    Article  CAS  Google Scholar 

  14. Kusar A, Zupancic A, Sentjurc M, Baricevic D. Free radical scavenging activities of yellow gentian (Gentiana lutea L.) measured by electron spin resonance. Hum Exp Toxicol. 2006;25:599–604.

    Google Scholar 

  15. Liu SB, Zhao R, Li XS, et al. Attenuation of reserpine-induced pain/depression dyad by gentiopicroside through downregulation of GluN2B receptors in the amygdala of mice. Neuromolecular Med. 2014;16:350–9.

    Article  CAS  Google Scholar 

  16. Liu SB, Ma L, Guo HJ, et al. Gentiopicroside attenuates morphine rewarding effect through downregulation of GluN2B receptors in nucleus accumbens. CNS Neurosci Ther. 2012;18:652–8.

    Article  CAS  Google Scholar 

  17. Mahady GB, Pendland SL, Stoia A, et al. In vitro susceptibility of Helicobacter pylori to botanical extracts used traditionally for the treatment of gastrointestinal disorders. Phytother Res. 2005;19:988–91.

    Article  Google Scholar 

  18. McMullen MK, Whitehouse JM, Whitton PA, Towell A. Bitter tastants alter gastric-phase postprandial haemodynamics. J Ethnopharmacol. 2014;154:719–27.

    Article  Google Scholar 

  19. Menković N, Savikin-Fodulović K, Savin K. Chemical composition and seasonal variations in the amount of secondary compounds in Gentiana lutea leaves and flowers. Planta Med. 2000;66:178–80.

    Article  Google Scholar 

  20. Menkovic N, Juranic Z, Stanojkovic T, et al. Radioprotective activity of Gentiana lutea extract and mangiferin. Phytother Res. 2010;24:1693–6.

    Article  CAS  Google Scholar 

  21. Mennella I, Fogliano V, Ferracane R, et al. Microencapsulated bitter compounds (from Gentiana lutea) reduce daily energy intakes in humans. Br J Nutr. 2016;1–10.

    Google Scholar 

  22. Nastasijević B, Lazarević-Pašti T, Dimitrijević-Branković S, et al. Inhibition of myeloperoxidase and antioxidative activity of Gentiana lutea extracts. J Pharm Biomed Anal. 2012;66:191–6.

    Article  Google Scholar 

  23. Olivier DK, van Wyk BE. Bitterness values for traditional tonic plants of southern Africa. J Ethnopharmacol. 2013;147:676–9.

    Article  CAS  Google Scholar 

  24. Oztürk N, Başer KH, Aydin S, et al. Effects of Gentiana lutea ssp. symphyandra on the central nervous system in mice. Phytother Res. 2002;16:627–31.

    Google Scholar 

  25. Oztürk N, Korkmaz S, Oztürk Y, Başer KH. Effects of gentiopicroside, sweroside and swertiamarine, secoiridoids from gentian (Gentiana lutea ssp. symphyandra), on cultured chicken embryonic fibroblasts. Planta Med. 2006;72:289–94.

    Google Scholar 

  26. Oztürk N, Herekman-Demir T, Oztürk Y, et al. Choleretic activity of Gentiana lutea ssp. symphyandra in rats. Phytomedicine. 1998;5:283–8.

    Google Scholar 

  27. Savikin K, Menković N, Zdunić G et al. Antimicrobial activity of Gentiana lutea L. extracts. Z Naturforsch C. 2009;64:339–42.

    Google Scholar 

  28. Schmieder A, Schwaiger S, Csordas A, et al. Isogentisin—a novel compound for the prevention of smoking-caused endothelial injury. Atherosclerosis. 2007;194:317–25.

    Article  CAS  Google Scholar 

  29. Toriumi Y, Kakuda R, Kikuchi M, et al. New triterpenoids from Gentiana lutea. Chem Pharm Bull (Tokyo). 2003;51:89–91.

    Article  CAS  Google Scholar 

  30. Waltenberger B, Liu R, Atanasov AG, et al. Nonprenylated xanthones from Gentiana lutea, Frasera caroliniensis, and Centaurium erythraea as novel inhibitors of vascular smooth muscle cell proliferation. Molecules. 2015;20:20381–90.

    Article  CAS  Google Scholar 

  31. Wölfle U, Haarhaus B, Seiwerth J, et al. The herbal bitter drug Gentiana lutea modulates lipid synthesis in human keratinocytes in vitro and in vivo. Int J Mol Sci. 2017;18, pii: E1814.

    Google Scholar 

  32. Yen TL, Lu WJ, Lien LM, et al. Amarogentin, a secoiridoid glycoside, abrogates platelet activation through PLC γ 2-PKC and MAPK pathways. Biomed Res Int. 2014;2014:728019.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shahid Akbar .

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Akbar, S. (2020). Gentiana lutea L. (Gentianaceae). In: Handbook of 200 Medicinal Plants. Springer, Cham. https://doi.org/10.1007/978-3-030-16807-0_102

Download citation

Publish with us

Policies and ethics